BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26849232)

  • 1. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
    Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
    Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
    Horibe R; Hirohashi Y; Asano T; Mariya T; Suzuki T; Takaya A; Saijo H; Shionoya Y; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Watanabe K; Atsuyama E; Toji S; Hirano H; Hasegawa T; Takahashi H; Sato N; Torigoe T
    PLoS One; 2017; 12(3):e0171460. PubMed ID: 28248963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
    Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
    Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
    Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
    Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.
    Yasuda K; Hirohashi Y; Mariya T; Murai A; Tabuchi Y; Kuroda T; Kusumoto H; Takaya A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Hirano H; Hasegawa T; Saito T; Sato N; Torigoe T
    Oncotarget; 2017 May; 8(19):31540-31553. PubMed ID: 28415561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
    Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells.
    Takahashi A; Hirohashi Y; Torigoe T; Tamura Y; Tsukahara T; Kanaseki T; Kochin V; Saijo H; Kubo T; Nakatsugawa M; Asanuma H; Hasegawa T; Kondo T; Sato N
    PLoS One; 2013; 8(11):e69095. PubMed ID: 24244262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
    Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
    Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.
    Yasuda K; Hirohashi Y; Kuroda T; Takaya A; Kubo T; Kanaseki T; Tsukahara T; Hasegawa T; Saito T; Sato N; Torigoe T
    Biochem Biophys Res Commun; 2016 Apr; 472(4):643-7. PubMed ID: 26969274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
    Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
    Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
    Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
    PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
    Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
    Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
    Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
    Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CTCFL/BORIS for the immunotherapy of cancer.
    Loukinov D
    Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer.
    Mariya T; Hirohashi Y; Torigoe T; Tabuchi Y; Asano T; Saijo H; Kuroda T; Yasuda K; Mizuuchi M; Saito T; Sato N
    Oncotarget; 2016 May; 7(18):26806-22. PubMed ID: 27072580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.
    Link PA; Zhang W; Odunsi K; Karpf AR
    Cancer Immun; 2013; 13():6. PubMed ID: 23390377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.
    Ogawa T; Hirohashi Y; Murai A; Nishidate T; Okita K; Wang L; Ikehara Y; Satoyoshi T; Usui A; Kubo T; Nakastugawa M; Kanaseki T; Tsukahara T; Kutomi G; Furuhata T; Hirata K; Sato N; Mizuguchi T; Takemasa I; Torigoe T
    Oncotarget; 2017 Dec; 8(68):112550-112564. PubMed ID: 29348846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.